In normal part of cancer samples, the expression of genes that negatively regulate the MyD88-independent TLR signaling pathway and genes that positively regulate prostaglandin E synthesis were enhanced in CD14+CD11c+CD163low cells compared to CD14−CD11c+ cells. The gene discussed is MYD88; the disease is cancer.